Search alternatives:
linear decrease » linear increase (Expand Search)
latent decrease » latency decreased (Expand Search), largest decrease (Expand Search), content decreased (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
linear decrease » linear increase (Expand Search)
latent decrease » latency decreased (Expand Search), largest decrease (Expand Search), content decreased (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
-
13781
-
13782
Effect of mutations on neutralization by antibodies elicited by 2x BNT162b2 vaccination, Delta breakthrough after 2x mRNA vaccination, or primary Delta infection.
Published 2022“…Points represent the geometric mean across cohorts (NT50s plotted in (A)). Error bars represent geometric standard deviation. …”
-
13783
-
13784
-
13785
-
13786
-
13787
Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization
Published 2018“…Conclusions: This study demonstrates that both subconjunctival and topical administrations of bevacizumab inhibit corneal neovascularization and decrease inflammation and fibroblast activity in a rat model of corneal neovascularization induced by alkali burn.…”
-
13788
-
13789
-
13790
-
13791
-
13792
-
13793
-
13794
-
13795
Modeling Chemotherapeutic Neurotoxicity with Human Induced Pluripotent Stem Cell-Derived Neuronal Cells
Published 2015“…We show the potential of the model for gene perturbation studies by demonstrating decreased expression of <i>TUBB2A</i> results in significantly increased sensitivity of neurons to paclitaxel (0.23 ± 0.06 decrease in total neurite outgrowth, P = 0.011). …”
-
13796
-
13797
-
13798
-
13799
Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco
Published 2011“…In the longitudinal analysis, there was a 1.1% net decrease in mean BMD in the TDF vs. the pre-treatment/placebo group at the femoral neck (95% CI 0.4–1.9%), 0.8% net decline at the total hip (95% CI 0.3–1.3%), and 0.7% at the L2–L4 spine (95% CI −0.1–1.5%). …”
-
13800